

Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1422, 2012-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. :


By Vidal Xavier Ibáñez Luisa Vendrell Lourdes Conforti Ana Laporte Joan-Ramon
Drug Safety, Vol. 31, Iss. 2, 2008-01 ,pp. :


By Tsu Laura V. Berry Andrew Wald Erin Ehrlich Cassandra
The Consultant Pharmacist, Vol. 30, Iss. 7, 2015-07 ,pp. :


Risk of major bleeding with apixaban in ACS
Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. :


Celecoxib and rofecoxib: risk of GI bleeding
Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. :